Clinical Trials Browser

Phase 2/3 × Interventional × Lymphatic Abnormalities × Clear all

NCT05948943 2026-02-13

EPIK-L1

Phase 2/3 Recruiting

Lymphangioma, Lymphangioma, Cystic, Lymphatic Abnormalities

NCT00010452 2015-03-25

Study of Picibanil (OK432) Sclerotherapy in Children With Macrocystic Lymphatic Malformations

Phase 2/3 Completed

Lymphangioma, Lymphangioma, Cystic, Lymphatic Abnormalities